GLP-1

G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight…

$An x-ray image of an ulnar fracture.$

Moderate- to high-quality evidence from an umbrella review on non-cardiometabolic outcomes reinforced links between GLP-1 therapies and risks…

For the first time, regulators have approved a small-molecule pill targeting glucagon-like peptide1 (GLP-1) for weight loss.…

The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily,…

Millions of Britons using GLP-1 weight loss medications are beginning to alter how they drink, dine and choose…

As GLP-1 medications grow in popularity not just for treating diabetes but also for weight loss, some people…

Create Wellness launched on Monday a Creatine + Electrolyte mix that will be available on Create’s website, Amazon,…

Obesity Beyond GLP-1s: Oral Formulations Take Center Stage Citeline News & InsightsUS weight-loss drugmakers slash prices in fight to…

IntroductionHow do GLP-1RAs work?The relationship between obesity and cancerWhat current research shows about GLP-1 drugs and cancer riskConflicting…

JACKSONVILLE, Fla. – For some, GLP-1 drugs feel like a weight-loss miracle. For others, the weight comes right…

We need your help now Support from readers like you keeps The Journal open. You are visiting us…

The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection.…

All about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weight